Honest Open Proud for Psychotic and Bipolar Disorder in Norway
HOP-NOR
Evaluation of a Norwegian Adaptation of the Honest Open Proud Program for Adults With Psychotic and Bipolar Disorders in an Outpatient Setting
2 other identifiers
interventional
40
1 country
2
Brief Summary
The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2024
CompletedFirst Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedMay 2, 2024
April 1, 2024
9 months
April 22, 2024
April 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stigma Stress Scale (Rüsch, Corrigan, Wassel et al., 2009; Rüsch, Corrigan, Powell et al., 2009)
8 items, from 1 (strongly disagree) to 7 (strongly agree)
Change from T0 to T1 and T2 (assessed at T0 = week 0; T1 =week 3; T2 = week 6)
Secondary Outcomes (7)
Disclosure Distress (Rüsch et al., 2014a)
Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)
Warwick and Edinburgh Wellbeing Scale (WEMWBS) (Tennant et al 2007)
Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)
Satisfaction with life (Lehman, 1988)
Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)
The Questionnaire about the Process of Recovery - 15 (QPR-15) (Niel et al 2007)
Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)
Internalised Stigma of Mental Illness Inventory (ISMI-10) (Boyd, Otilingam, & Deforge, 2014)
Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)
- +2 more secondary outcomes
Other Outcomes (4)
Disclosure
Assessed at T1 and T2 (T1= week 3 and T2 = week 6)
Feasibility of HOP program
Tracked during trial and evaluated after completion (T2 = week 6)
Acceptability of HOP program participants
Assessed after T2 = week 6
- +1 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALIntervention group: receives the HOP program consisting of four 2-hour sessions divided between week 1, week 2, week 3 and week 6, in groups of 4-10 participants, using a Norwegian adaptation of HOP workbook. The intervention group also receives treatment as usual, consisting of weekly or monthly appointments with a mental health care professional at an outpatient unit in the public mental health care service. The appointments can involve medication management, psychoeducation, support therapy or psychotherapy.
Waiting list control group
NO INTERVENTIONWaiting list control group: receives only treatment as usual, consisting of weekly or monthly appointments with a mental health care professional at an outpatient unit in the public mental health care service. The appointments can involve medication management, psychoeducation, support therapy or psychotherapy. They are offered the HOP program after the trial.
Interventions
The HOP program involves peer facilitated sessions, in which different stigma and disclosure related topics are introduced to the group, relevant tasks are completed individually, followed by group or two-and-two discussions related to the following topics: week 1 = pros and cons with disclosure, week 2 = different ways of disclosing, week 3 = formulating individual decisions of disclosure, week 6 = evaluating disclosure or non-disclosure in practice.
Eligibility Criteria
You may qualify if:
- Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to International Classification of Diseases 10th Revision (ICD-10)
- Age 18 to 65
- Ability to provide written informed consent.
- Fluent in Norwegian (needed for self-report measures)
- Experience difficulties with stigma and disclosure regarding mental illness.
You may not qualify if:
- Intellectual disability
- Organic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- University of Oslocollaborator
Study Sites (2)
Nydalen DPS, Division of Mental Health and Addiction, Oslo University Hospital
Oslo, 0351, Norway
Søndre Oslo DPS, Division of Mental Health and Addiction, Oslo University Hospital
Oslo, 1281, Norway
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carmen Simonsen, PhD
Department of Psychology, University of Oslo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 25, 2024
Study Start
April 20, 2024
Primary Completion
December 31, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
May 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
The study protocol can be shared, but not the the actual data.